Related Experiment Video
Updated: Aug 16, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Control of hypertension with single daily doses of sotalol hydrochloride
Insights
Once-daily sotalol effectively controlled blood pressure in hypertensive patients for 3 months. While blood pressure remained stable, some patients experienced pulse rate escape from beta-blockade, with minimal side effects.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypertension management requires effective and convenient therapeutic strategies.
- Beta-blockers are a cornerstone in treating high blood pressure.
- Assessing novel dosing regimens for established antihypertensives is crucial.
Purpose of the Study:
- To evaluate the efficacy and tolerability of a once-daily sotalol dosage regimen in previously untreated hypertensive patients.
- To determine the optimal sotalol dose for sustained blood pressure control.
Main Methods:
- A prospective study involving 12 hypertensive patients.
- Initial dosage titration of sotalol to stabilize diastolic pressure below 100 mmHg.
- Maintenance therapy with a constant once-daily dose for 3 months, monitoring blood pressure and pulse rate.
Main Results:
- Sotalol effectively controlled blood pressure for at least 26 hours in all patients on a once-daily regimen.
- Eight out of 12 patients achieved adequate control with 320 mg or less daily (mean 190 mg).
- Pulse rate showed evidence of escape from beta-blockade despite sustained blood pressure control; only one patient reported vivid dreams.
Conclusions:
- Once-daily sotalol is an effective antihypertensive treatment for previously untreated patients.
- Sotalol demonstrates good tolerability with a low incidence of side effects.
- Further investigation into the pulse rate escape phenomenon with once-daily sotalol is warranted.
Abstract:
A study was carried out in 12 previously untreated hypertensive patients to assess the efficacy of sotalol given in a once-daily dosage regimen. After an initial dosage titration period (mean 3 weeks) during which diastolic pressure was stabilized at less than 100 mmHg, all patients were satisfactorily maintained on a constant once-daily dose of sotalol for 3 months. Eight of the 12 patients required 320 mg or less daily (mean dose 190 mg). Whilst blood pressure remained controlled for at least 26 hours after daily doses the pulse rate, counted at the same time, showed escape from beta-blockade. Side-effects (vivid dreams) were reported in only 1 patient.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Heart Failure V: Medical Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

